Baxter International Inc 's Cash & cash equivalent grew by 6.64 % in the Q2 2026 sequentially, while Current Liabilities decreased, this led to improvement in Baxter International Inc 's Quick Ratio to 0.6, Quick Ratio remained below Baxter International Inc average.

Within Medical Equipment & Supplies industry 139 other companies have achieved higher Quick Ratio than Baxter International Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 2229 to 2455.

Explain Quick Ratio?
How much Cash & cash equivalents BAX�s has?
What are BAX�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BAX Quick Ratio	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3	(Jun 30 2025) Q2
Y / Y Current Liabilities Change	22.18 %	6.09 %	-54.38 %	-39.11 %	-52.06 %
Y / Y Cash & cash equivalent Change	27.58 %	-12.07 %	11.45 %	21.55 %	7.12 %
Quick Ratio MRQ	0.6	0.55	0.66	0.46	0.57
BAX's Total Ranking	# 2455	# 2229	# 2182	# 2240	# 1767
Seq. Current Liabilities Change	-2.76 %	24.34 %	-21.32 %	28.45 %	-15.57 %
Seq. Cash & cash equivalent Change	6.64 %	2.59 %	13.9 %	2.37 %	-26.5 %

Quick Ratio second quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 140
Healthcare Sector	# 716
Overall Market	# 2455

Quick Ratio Statistics
High	Average	Low
1.49	0.66	0.2
(Jun 30 2017)		(Dec. 29. 2005)

Financial Statements
Baxter International Inc 's Current Liabilities	$ 3,591 Millions	Visit BAX's Balance sheet
Baxter International Inc 's Cash & cash equivalent	$ 2,151 Millions	Visit BAX's Balance sheet
Source of BAX's Sales		Visit BAX's Sales by Geography

Cumulative Baxter International Inc 's Quick Ratio

BAX's Quick Ratio for the trailling 12 Months

BAX Quick Ratio	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months	(Jun 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-26.67 %	-40.08 %	-47.77 %	-36.53 %	-27.35 %
Y / Y Cash & cash equivalent TTM Growth	9.72 %	4.86 %	1.16 %	-16.05 %	-45.7 %
Quick Ratio TTM	0.56	0.55	0.58	0.45	0.37
Total Ranking TTM	# 4106	# 4066	# 3101	# 3288	# 3185
Seq. Current Liabilities TTM Growth	4.87 %	1.61 %	-21.2 %	-12.68 %	-14.3 %
Seq. Cash & cash equivalent TTM Growth	6.29 %	-3.61 %	2.7 %	4.27 %	1.59 %

Quick ratio ranking by company, industry and sector >> Back to BAX Financial Strength Comparisons >> Go to Compare BAX Quick Ratio to its Competitors

On the trailing twelve months basis BAX Cash & cash equivalent grew by 27.58 % in Q2 2026 year on year, faster than Current Liabilities, this led to increase in in Baxter International Inc 's Quick Ratio to 0.56, Quick Ratio remained below BAX average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 206 other companies have achieved higher Quick Ratio than Baxter International Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 4066 to 4106.

Explain Quick Ratio?
How much Cash & cash equivalents BAX�s has?
What are BAX�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 207
Healthcare Sector	# 909
Within the Market	# 4106

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.3	0.69	0.29
(Dec 31 2017)		(Dec. 29. 2005)

Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Jun 30 2026 MRQ Cash & cash equivalent	Jun 30 2026 MRQ Current Liabilities
Seastar Medical Holding Corp	1.60	$ 6.959 Millions	$ 4.353 Millions
Tela Bio Inc	1.59	$ 30.424 Millions	$ 19.080 Millions
Conexeu Sciences Inc	1.55	$ 1.971 Millions	$ 1.272 Millions
Inogen Inc	1.49	$ 105.539 Millions	$ 70.864 Millions
Dariohealth Corp	1.49	$ 14.254 Millions	$ 9.578 Millions
Myomo Inc	1.45	$ 15.686 Millions	$ 10.805 Millions
Envoy Medical Inc	1.43	$ 19.679 Millions	$ 13.807 Millions
Nephros Inc	1.40	$ 4.697 Millions	$ 3.344 Millions
Envista Holdings Corporation	1.39	$ 1,125.600 Millions	$ 807.300 Millions
Medtronic Plc	1.36	$ 16,068.000 Millions	$ 11,799.000 Millions
Sanara Medtech Inc	1.31	$ 16.421 Millions	$ 12.494 Millions
Globus Medical Inc	1.24	$ 595.142 Millions	$ 479.347 Millions
Lucid Diagnostics Inc	1.21	$ 33.404 Millions	$ 27.516 Millions
Sintx Technologies Inc	1.21	$ 3.590 Millions	$ 2.977 Millions
Vaso Corporation	1.17	$ 38.291 Millions	$ 32.863 Millions
Koru Medical Systems Inc	1.15	$ 8.288 Millions	$ 7.180 Millions
Establishment Labs Holdings Inc	1.10	$ 71.157 Millions	$ 64.558 Millions
Treace Medical Concepts Inc	1.10	$ 45.619 Millions	$ 41.496 Millions
Resmed Inc	1.05	$ 1,469.234 Millions	$ 1,395.110 Millions
Adagio Medical Holdings inc	1.02	$ 7.740 Millions	$ 7.562 Millions
Plus Therapeutics Inc	1.00	$ 8.587 Millions	$ 8.567 Millions
Pavmed Inc	1.00	$ 4.070 Millions	$ 4.088 Millions
Sonoma Pharmaceuticals Inc	0.98	$ 5.338 Millions	$ 5.447 Millions
Nuwellis Inc	0.98	$ 3.922 Millions	$ 4.008 Millions
Electrocore Inc	0.97	$ 11.543 Millions	$ 11.933 Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________	0.96	$ 10.924 Millions	$ 11.366 Millions
Medline Inc	0.96	$ 2,677.000 Millions	$ 2,803.000 Millions
Neuronetics Inc	0.88	$ 24.947 Millions	$ 28.309 Millions
Orthopediatrics Corp	0.87	$ 45.879 Millions	$ 52.852 Millions
Haemonetics Corporation	0.85	$ 223.384 Millions	$ 263.235 Millions

Date modified: 2026-09-13T23:20:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.